Dr Kostas Hatzixanthis is a molecular biologist, microbiologist and biochemist by training with 9 years postdoctoral experience. Kostas has over 6 year’s industrial experience in novel antibacterial development. He has expertise in bioprocess development of biologics, technology transfer and conduct of early stage clinical trials. During his time at Procarta, he has raised significant funds via grant applications at National and European level. Kostas joined Procarta as Director of Research in June 2012. Prior to that he held a Senior Scientist position in Downstream Processing and acted as a Clinical Trial Coordinator for Phico Therapeutics, UK.